DSIP (10mg Vial) Dosage Protocol
Delta Sleep-Inducing Peptide — experimental, unapproved research peptide; no standardized dosing.
Why DSIP draws research interest
These are the directions researchers and the peptide community most often explore DSIP for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Sleep regulation
The primary reason DSIP is sought; investigated in preclinical and early human research on delta-wave sleep and sleep onset.
Stress & HPA axis
Explored in animal research as a modulator of stress responses and cortisol; investigational only, not an approved therapy.
Pain & withdrawal
Studied in older clinical research on chronic pain and opioid withdrawal symptoms; findings preliminary and unreplicated at scale.
Neuroprotection
Researched in animal models for effects on oxidative stress and neuronal resilience; remains experimental and unapproved.
Research context, not medical advice. Nothing here says DSIP treats, cures, or improves any condition. Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
Mix & measure DSIP · 10 mg
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →
Quickstart Highlights
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its proposed effects on sleep architecture and stress modulation[1][2]. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. DSIP is an unapproved research chemical — never approved by the FDA or EMA for any indication; human evidence is limited and dated, with no standardized dosing established. Presented for research and educational use only.
Add 3.0 mL bacteriostatic water to one 10 mg vial → ~3.33 mg/mL (3,333 mcg/mL), a practical dilution for accurate dosing.
100–300 mcg once daily with gradual titration; advanced use up to 500 mcg.
At ~3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and avoid freeze–thaw cycles.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.
Dosing & Reconstitution Guide
A single practical dilution with accurate once-daily dosing, step by step
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg vial → final concentration ~3.33 mg/mL (3,333 mcg/mL).
Typical daily range: 100–300 mcg once daily with gradual titration; advanced use up to 500 mcg.
Easy measuring: At ~3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 syringe.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and avoid freeze–thaw cycles.
Frequency: one subcutaneous injection each day, typically in the evening before bedtime, titrating up gradually as tolerated[5][6]. Advanced users may extend toward a ceiling of 500 mcg (15 units, 0.15 mL). These figures come from limited reference literature, not from approved human dosing.
Reconstitution Steps
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
For low-volume doses (≤10 units / ≤0.10 mL in Weeks 1–2), a 30- or 50-unit insulin syringe improves readability. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Quantities below assume an 8–12 week daily protocol with gradual titration (~200 mcg/day average).
At ~200 mcg/day, a 10 mg vial lasts several weeks; plan a few vials per course.
- 8 weeks at ~200 mcg/day: ~2 vials
- 12 weeks at ~200 mcg/day: ~2 vials
- 12 weeks at ~300 mcg/day: ~3 vials
- Per week: 7 syringes (1/day)
- 8 weeks: ~56 syringes
- 12 weeks: ~84 syringes
Use ~3.0 mL per 10 mg vial for reconstitution.
- 3 vials (9 mL): 1 bottle
- 5 vials (15 mL): 2 bottles
- 6 vials (18 mL): 2 bottles
One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: ~112 swabs → 2 boxes
- 12 weeks: ~168 swabs → 2 boxes
Protocol Overview
A concise summary of the once-daily regimen, drawn from the limited reference literature.
- ▪Goal: Studied for its proposed support of slow-wave (delta) sleep and stress/neuroendocrine modulation — effects described in research but not established in approved clinical use[3][4].
- ▪Schedule: Daily subcutaneous injections for 4–8 weeks, optionally extended to ~12 weeks with periodic breaks.
- ▪Dose Range: 100–300 mcg daily with gradual titration; advanced up to 500 mcg.
- ▪Reconstitution: 3.0 mL bacteriostatic water per 10 mg vial gives ~3.33 mg/mL for accurate unit measurements.
- ▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and avoid repeated freeze–thaw.
Dosing Protocol
A suggested daily titration approach based on common reference doses.
- ▪Start: Begin at 100 mcg once daily; increase by ~50 mcg every 1–2 weeks as tolerated.
- ▪Target: Reach about 250–300 mcg daily by Weeks 4–8.
- ▪Frequency: Once per day subcutaneously, typically before bedtime.
- ▪Cycle Length: Typically 4–8 weeks; optional extension to 12 weeks with periodic breaks.
- ▪Timing: Evening administration preferred; rotate injection sites systematically.
Storage Instructions
Correct storage is what preserves the peptide’s stability and activity.
- ▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
- ▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 4 weeks; avoid freeze–thaw, as freezing can denature peptides[8].
- ▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
- ▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.
Important Notes
Practical points that keep daily administration safe and consistent.
- ▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
- ▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
- ▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
- ▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
- ▪Regulatory note: DSIP is not approved by the FDA or EMA for any indication — it is an unapproved research chemical with no established safety profile[6].
How This Works
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is a naturally occurring nonapeptide (9 amino acids) first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain[1].
No definitive receptor or pathway has been mapped for DSIP. Mechanistic studies propose that it may influence sleep through interactions with GABAergic and opioid systems, but these neurotransmitter interactions remain unconfirmed[10]. Some research describes increased delta-wave (slow-wave) sleep duration without major changes to REM architecture[3].
Beyond sleep, DSIP has been studied for proposed stress-protective and adaptogenic properties, potentially through modulation of the hypothalamic-pituitary-adrenal (cortisol/ACTH) axis[4][11]. These remain proposed effects, not confirmed clinical outcomes.
Important caveat: human evidence for DSIP is limited and dated, and decades of study never reached regulatory approval. Effects on sleep, stress, recovery, or longevity should be read as studied or proposed, not proven.
DSIP is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.
Lifestyle Factors
Complementary habits that may support sleep and stress goals alongside the protocol.
- ▪Sleep schedule: Keep consistent sleep-wake times to reinforce your circadian rhythm.
- ▪Light & stimulants: Limit blue-light exposure and stimulants (caffeine, nicotine) in the hours before bed.
- ▪Environment: Create a cool, dark, quiet sleep environment.
- ▪Activity: Incorporate regular physical activity, ideally earlier in the day.
- ▪Stress: Manage stress through relaxation techniques such as meditation and deep breathing.
Potential Benefits & Side Effects
Observations from limited and dated preclinical and clinical literature; nothing here is established or approved, and individual results vary.
Proposed Effects (Studied)
- ▪Slow-wave sleep: Some studies report deeper slow-wave sleep and improved subjective sleep quality[3][5].
- ▪Stress modulation: Research suggests proposed stress-protective and anxiolytic-like effects[4][11].
- ▪Tolerance: Some studies indicate DSIP does not appear to induce pharmacological tolerance with continued use[2].
- ▪Note: These effects are not proven — human evidence is limited and dated, with no standardized dosing or approved use.
Side Effects & Cautions
- ▪Injection-site reactions: Occasional mild redness, tenderness or soreness may occur with subcutaneous administration; rotating sites helps.
- ▪Limited safety data: Long-term human safety data is limited; periodic breaks are recommended as a precaution[6].
- ▪Unapproved: DSIP is not approved by the FDA or EMA and is for research use only — not for human consumption.
Injection Technique
General subcutaneous technique, following established clinical best-practice guidance[12][13].
Pre-Injection Preparation
- ▪Wash your hands well with soap and water.
- ▪Wipe the vial stopper with an alcohol swab and let it air-dry.
- ▪Choose a site (abdomen at least 2 inches from the navel, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[13].
- ▪Draw the intended dose, then check for air bubbles and push any out.
Injection Procedure
- ▪Pinch a skinfold at the chosen site between thumb and forefinger.
- ▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[12].
- ▪Skip aspiration for subcutaneous shots — it isn’t needed[12].
- ▪Press the plunger slowly and steadily until it’s fully down.
- ▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
Post-Injection Care
- ▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
- ▪Return the reconstituted vial to the fridge right away.
- ▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
- ▪Watch the site for excess redness, swelling, or signs of infection.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides.
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
References
- 1
Proc Natl Acad Sci USA (1977)Schoenenberger GA, Monnier M — Characterization of a delta-electroencephalogram (-sleep)-inducing peptide isolated from rabbit brain.
- 2
European Journal of Anaesthesiology (2001)Delta sleep-inducing peptide: editorial review of proposed mechanisms and clinical context.
- 3
Neuropsychobiology (1983)Schneider-Helmert D, Schoenenberger GA — Effects of DSIP in man: multifunctional psychophysiological properties.
- 4
Ann N Y Acad Sci (2004)Sudakov KV et al. — Delta-sleep-inducing peptide sequelae: stress-protective effect.
- 5
Int J Clin Pharmacol Ther Toxicol (1981)Schneider-Helmert D — Acute and delayed effects of DSIP on human sleep behavior.
- 6
Neurosci Biobehav Rev (1984)Graf MV, Kastin AJ — Delta-sleep-inducing peptide (DSIP): a review.
- 7
Int J Pharm (2000)Wang W — Lyophilization and development of solid protein pharmaceuticals (stability and storage).
- 8
- 9
NCBI BookshelfMedication Administration: Subcutaneous Injections — aseptic technique and site rotation (Open RN Nursing Skills).
- 10
Int J Neurosci (1988)Yehuda S, Carasso RL — DSIP: proposed brain mechanisms and function.
- 11
Biull Eksp Biol Med (2003)Khvatova EM et al. — Delta sleep-inducing peptide: effect on oxidative stress in brain.
- 12
Centers for Disease Control and Prevention (CDC)Subcutaneous injection technique: angle, site and no-aspiration guidance.
- 13
NCBI Bookshelf (Open RN)Medication Administration: Subcutaneous Injections — clinical technique guidelines.
- 14
Prime Lab PeptidesResearch peptides catalog — purity specifications and certificates of analysis.
How to reconstitute DSIP
- 1Wipe the vial stopper and your bacteriostatic-water vial with an alcohol swab.
- 2Draw your chosen amount of bacteriostatic water and inject it slowly down the inner wall of the DSIP vial.
- 3Let it rest, then gently swirl until fully dissolved — do not shake.
- 4Refrigerate the reconstituted vial and draw each dose with a U-100 insulin syringe.
DSIP — frequently asked questions
How do I reconstitute a 10 mg vial of DSIP?
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.
How much bacteriostatic water should I add to DSIP?
There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.
What do the "units" on an insulin syringe mean?
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.
How should I store DSIP after mixing?
Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.
How many doses does a 10 mg vial of DSIP provide?
Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.
Is DSIP approved for human use?
No. DSIP is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.